Enhabit, Inc. (EHAB) P/E Ratio History
Insufficient DataValuation data unavailable. · Data 2022–2023
Loading P/E history...
P/E Ratio Analysis
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our EHAB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
EHAB Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
EHAB P/E vs Peers
Home Health & Hospice peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 20.8 | 1.03 | +23% | |
| $11B | 26.9 | 1.95 | +14% | |
| $1B | 36.9 | 3.66 | +18% | |
| $358B | 22.4 | - | -15% | |
| $52B | 42.4 | - | -1% | |
| $107B | 9.8Lowest | - | -62% | |
| $92B | 18.0 | 2.61 | -2% | |
| $107B | 15.9 | 0.75Best | +29%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
EHAB Historical P/E Data (2022–2023)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2023 Q1 | Mar 31 2023 | $13.91 | $0.78 | 17.7x | +49% |
| FY2022 Q4 | Dec 31 2022 | $13.16 | $1.25 | 10.5x | -11% |
| FY2022 Q3 | Sep 30 2022 | $14.04 | $1.70 | 8.3x | -30% |
| FY2022 Q2 | - | $22.97 | $2.09 | 11.0x | -7% |
Average P/E for displayed period: 11.9x
EHAB Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EHAB — Frequently Asked Questions
Quick answers to the most common questions about buying EHAB stock.
What is EHAB's P/E ratio?
Enhabit, Inc. (EHAB) trailing twelve-month P/E ratio is N/A, based on TTM diluted EPS of N/A. The 5-year average P/E is 11.9x and the historical range spans 8.3x to 17.7x.
Is EHAB stock overvalued or undervalued?
EHAB current P/E: N/A. 5-year average P/E: 11.9x. Percentile: N/A.
Is EHAB stock expensive?
EHAB is fairly valued relative to its own history. The current P/E of N/A is near the 5-year average of 11.9x (N/A percentile of historical range).
What is EHAB's historical P/E range?
Over the past 5 years, EHAB's P/E ratio has ranged from 8.3x to 17.7x, with a median of 11.0x and an average of 11.9x. The current P/E of N/A places the stock at the N/A percentile of this range. Full historical data spans 2022–2023.
How does EHAB's P/E compare to the S&P 500?
EHAB current P/E: N/A. S&P 500 median P/E: 21.8x.
How does EHAB's valuation compare to Healthcare peers?
Enhabit, Inc. P/E of N/A can be benchmarked against Healthcare peers in the comparison table on this page.
What is EHAB's PEG ratio?
EHAB PEG ratio is N/A. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is EHAB's earnings yield?
EHAB earnings yield is N/A, the inverse of its N/A P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.